IRIS
AVERSA, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.419
NA - Nord America 13.036
EU - Europa 6.974
SA - Sud America 1.651
AF - Africa 662
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 6
Totale 35.770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.626
SG - Singapore 5.300
CN - Cina 3.754
VN - Vietnam 1.782
IE - Irlanda 1.492
BR - Brasile 1.301
HK - Hong Kong 1.010
IT - Italia 915
SE - Svezia 914
FI - Finlandia 903
DE - Germania 779
TR - Turchia 698
ZA - Sudafrica 485
UA - Ucraina 434
FR - Francia 429
NL - Olanda 405
CA - Canada 285
GB - Regno Unito 188
RU - Federazione Russa 177
AR - Argentina 143
IN - India 135
BD - Bangladesh 130
IQ - Iraq 87
JP - Giappone 82
MX - Messico 72
AT - Austria 69
PL - Polonia 56
KR - Corea 51
EC - Ecuador 49
PH - Filippine 47
BE - Belgio 45
ES - Italia 39
ID - Indonesia 39
PK - Pakistan 39
VE - Venezuela 39
UZ - Uzbekistan 38
TH - Thailandia 35
CO - Colombia 32
CI - Costa d'Avorio 30
SA - Arabia Saudita 30
MA - Marocco 28
EG - Egitto 26
PY - Paraguay 26
CZ - Repubblica Ceca 24
EU - Europa 22
RO - Romania 21
TW - Taiwan 21
KE - Kenya 19
LT - Lituania 19
CL - Cile 18
JO - Giordania 16
IL - Israele 14
PE - Perù 14
SN - Senegal 12
BO - Bolivia 11
DZ - Algeria 11
OM - Oman 11
UY - Uruguay 11
NP - Nepal 10
PA - Panama 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
AZ - Azerbaigian 9
ET - Etiopia 9
KZ - Kazakistan 9
CR - Costa Rica 8
IR - Iran 7
JM - Giamaica 7
KG - Kirghizistan 7
MY - Malesia 7
PS - Palestinian Territory 7
TN - Tunisia 7
BG - Bulgaria 6
DO - Repubblica Dominicana 5
GR - Grecia 5
GT - Guatemala 5
GY - Guiana 5
NG - Nigeria 5
PT - Portogallo 5
QA - Qatar 5
SI - Slovenia 5
AO - Angola 4
AU - Australia 4
BH - Bahrain 4
BY - Bielorussia 4
CH - Svizzera 4
GA - Gabon 4
HN - Honduras 4
KH - Cambogia 4
RS - Serbia 4
AM - Armenia 3
BN - Brunei Darussalam 3
CG - Congo 3
CM - Camerun 3
DK - Danimarca 3
HU - Ungheria 3
LB - Libano 3
LY - Libia 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
Totale 35.715
Salva come PNG Salva come JPEG
Città #
Singapore 2.509
Dublin 1.492
Chandler 1.468
Ashburn 1.290
San Jose 1.238
Beijing 1.011
Hong Kong 971
Jacksonville 905
Izmir 623
Ho Chi Minh City 530
Santa Clara 511
Dallas 506
Nanjing 480
Johannesburg 461
Boardman 423
Hanoi 413
Dearborn 382
Princeton 352
San Mateo 330
Lauterbourg 313
Parma 303
Ann Arbor 236
Wilmington 235
Columbus 234
New York 226
Los Angeles 221
Toronto 183
Helsinki 158
Shenyang 154
Shanghai 149
Kunming 144
Nanchang 141
The Dalles 141
Moscow 135
Council Bluffs 115
Hebei 115
São Paulo 111
Jinan 100
Munich 97
Hefei 96
Des Moines 93
Changsha 92
Tianjin 86
Haiphong 81
Jiaxing 80
Buffalo 77
Da Nang 72
Tokyo 64
Düsseldorf 59
Guangzhou 56
Vienna 56
Milan 51
Frankfurt am Main 46
Norwalk 46
San Francisco 45
Seattle 45
Turku 42
Orem 41
Rome 39
Warsaw 39
Bologna 36
Brussels 36
Montreal 36
Brooklyn 35
Hangzhou 35
Rio de Janeiro 35
Tashkent 35
Hải Dương 34
London 33
Chicago 32
Belo Horizonte 31
Boston 31
Zhengzhou 31
Atlanta 30
Chennai 30
Abidjan 29
Chengdu 29
Kocaeli 29
Biên Hòa 28
Brasília 28
Woodbridge 28
Marseille 27
Stockholm 27
Jakarta 26
Falls Church 24
Bremen 23
Seoul 23
Baghdad 22
Dhaka 22
Houston 22
Denver 21
Mestre 21
Fremont 20
Haikou 20
Phoenix 20
Wuhan 20
Campinas 19
Curitiba 19
Mexico City 19
Guarulhos 18
Totale 21.796
Salva come PNG Salva come JPEG
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 253
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 216
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 210
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 208
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 205
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 203
The Proteasome and Myeloma-Associated Bone Disease 189
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 187
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 185
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 182
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 182
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. 181
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 180
Sindrome preleucemica 179
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 178
The -2518 A/G single nucleotide polymorphism of MCP-1 in myelofibrosis: functional characterization on ex-vivo patient cells. 178
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 176
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 176
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 172
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 172
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 168
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 167
PROTEIN KINASE Ce EXPRESSION IN PRIMARY MYELOFIBROSIS PLATELETS CORRELATES WITH CARDIOVASCULAR EVENTS 167
''Designed'' grafts for HLA-haploidentical stem cell transplantation 162
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 161
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 157
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 156
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 156
[Evaluation of the immunological status of patients with Hodgkin's disease] 155
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 155
ERK1/2 is the signaling pathway primarily activated in myeloid neoplasms carrying t(8;9)/PCM1-JAK2 fusion. A two cases report. 155
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 155
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients 153
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 152
A prospective survey of febrile events in hematological malignancies 151
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 151
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 151
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 150
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 150
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 150
Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk 149
Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation? 148
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 147
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 147
[Sequential polychemotherapeutic treatment of inoperable bronchogenic carcinoma] 146
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 145
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 144
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia. 143
Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. 142
Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. 141
Acute lymphoblastic leukaemia in Noonan syndrome. 140
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. 139
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 139
The osteoblastic niche in the context of multiple myeloma 138
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 138
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 137
Serie granulocitaria 134
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 133
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients. 133
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 133
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry 132
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 129
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 129
Allogeneic Hematopoietic stem cell transplantation and natural killer cell alloreactivity, 129
Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors 128
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 127
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. 126
The anti-myeloma effect of Lenalidomide is increased by hypoxia-inducible factor (HIF)-1a inhibition in multiple myeloma cells both in vitro and in vivo 126
Human thrombopoiesis depends on PKCdelta/PKCepsilon functional couple 126
Mieloma multioplo ed altre discrasie linfoplasmacellulari 125
T cell depleted haploidentical transplantation: positive selection. 125
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. 125
TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 125
Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi 125
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide 124
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 122
Allogeneic transplantation across the HLA barriers. 121
Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. 121
[T-cell depletion today: pros and cons] 121
Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation 121
T cell depleted HLA-identical bone marrow transplants 120
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils. 120
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 119
Amiloidosi 119
The haploidentical option for high-risk haematological malignancies. 119
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma 119
BORTEZOMIB WITH HIGH DOSE MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND IMPROVES THE RESPONSE RATE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA 119
T Cell Responses in Fungal Infections 117
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 116
Allogeneic transplants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. GITMO. Gruppo Italiano Trapianto di Midollo Osseo. 115
[Diffuse bone metastases, prevalently blastic, of adenocarcinoma of the colon] 115
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in myeloma-induced angiogenesis and bone destruction in vitro and in vivo 115
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 114
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 114
Trascriptome Analysis of Bone Marrow CD14+ Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance 113
Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients 113
Germline PTPN11 mutation affecting exon 8 in a case of syndromic juvenile myelomonocytic leukemia 112
Relationship between bone imaging features and bone marrow cytokine and chemokine profiles in patients with monoclonal gammopathy 112
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 112
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 112
Totale 14.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021313 0 0 0 0 0 0 0 0 0 46 244 23
2021/20221.512 19 15 17 64 45 28 170 257 62 197 85 553
2022/20235.299 688 350 244 381 463 586 60 352 1.913 35 165 62
2023/20241.800 128 230 53 60 155 515 68 116 25 68 144 238
2024/20256.419 62 398 520 413 640 424 182 367 838 627 605 1.343
2025/202612.887 1.107 1.277 1.810 1.038 2.185 781 1.812 455 1.652 770 0 0
Totale 36.075